Jerusalem, March 31, 2026 - Alpha Tau Medical Ltd . (Nasdaq: DRTS, DRTSW) (“Alpha Tau”), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT ®  today announced that an abstract presenting results of two clinical trials in Jerusalem in patients with pancreatic cancer has been accepted for an oral presentation at Digestive Disease Week (DDW) 2026, the world’s premier international gastroenterology conference . This marks the first time that clinical result

Jerusalem, March 16, 2026 - Alpha Tau Medical Ltd . (Nasdaq: DRTS, DRTSW) ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT ®  today announced that CFO Raphi Levy will present at the Sidoti Virtual Small Cap Conference taking place on March 18 - 19, 2026. Event: Sidoti Virtual Small Cap Conference Format: Company Presentation Date: March 18, 2026 Time: 10:00 – 10:30AM ET Location: Virtual Mr. Levy will be available for 1x1 investor meeti

Alpha Tau Announces Full Year 2025 Financial Results and Provides Corporate Update